Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Cash from Investing Activities (2017 - 2025)

Historic Cash from Investing Activities for Catheter Precision (VTAK) over the last 9 years, with Q3 2025 value amounting to -$28000.0.

  • Catheter Precision's Cash from Investing Activities changed N/A to -$28000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$51000.0, marking a year-over-year increase of 4000.0%. This contributed to the annual value of -$67000.0 for FY2024, which is 983.61% down from last year.
  • Catheter Precision's Cash from Investing Activities amounted to -$28000.0 in Q3 2025.
  • In the past 5 years, Catheter Precision's Cash from Investing Activities registered a high of $3.3 million during Q3 2021, and its lowest value of -$45000.0 during Q2 2024.
  • For the 5-year period, Catheter Precision's Cash from Investing Activities averaged around $260285.7, with its median value being -$11500.0 (2025).
  • Per our database at Business Quant, Catheter Precision's Cash from Investing Activities skyrocketed by 1464347.83% in 2021 and then tumbled by 18571.43% in 2023.
  • Over the past 5 years, Catheter Precision's Cash from Investing Activities (Quarter) stood at -$1000.0 in 2021, then soared by 2200.0% to $21000.0 in 2022, then tumbled by 185.71% to -$18000.0 in 2023, then plummeted by 150.0% to -$45000.0 in 2024, then soared by 37.78% to -$28000.0 in 2025.
  • Its Cash from Investing Activities was -$28000.0 in Q3 2025, compared to -$13000.0 in Q2 2025 and -$10000.0 in Q1 2025.